Analgesics in Saudi Arabia

Summary

Analgesics in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage: adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

• Get a detailed picture of the analgesics industry
• Pinpoint growth sectors and trends and identify factors driving change
• Understand the competitive environment, the market's major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Contents

• 1. Executive Summary
• 2. Operating Environment
  • 2.1 Otc Registration and Classification
  • 2.2 Vitamins & Dietary Supplements Registration and Classification
  • 2.3 Advertising
  • 2.4 Packaging and Labelling
  • 2.5 Distribution
  • 2.6 De-Listing or De-Reimbursement
  • 2.7 Traditional Remedies
  • 2.8 Homeopathy
  • 2.9 Generics
  • 2.10 Consumer Expenditure on Health Goods and Medical Services
  • 2.11 Life Expectancy
• 3. Otc Healthcare Sales
  • 3.1 Market Performance
  • 3.2 Switches
  • 3.3 Competitive Environment
  • 3.4 Leading Company Profile - Glaxo Saudi Arabia Ltd/Glaxosmithkline
  • 3.5 Leading Company Profile - Julphar
  • 3.6 Leading Company Profile - Saudi Pharmaceutical Industries and Medical Appliance Co (Spimaco)
  • 3.7 Leading Company Profile - Tabuk Pharmaceutical Manufacturing Co
  • 3.8 Retail Distribution
  • 3.9 Retailer Activity and Private Label Trends
  • 3.10 Forecast Market Performance
• 4. Analgesics Sales
  • 4.1 Sector Performance
  • 4.2 Topical Analgesics by Herbal/Standard Split
• 5.Definitions
• List of Summaries
  • Summary 1 Otc Healthcare Switches
  • Summary 2 Glaxo Saudi Arabia Ltd/Glaxosmithkline: Operational Indicators 2004
  • Summary 3 Julphar: Operational Indicators 2004
  • Summary 4 Spimaco: Operational Indicators 2004
  • Summary 5 Tabuk Pharmaceutical Manufacturing Co: Operational Indicators 2004
  • Summary 6 Analgesics: New Product Launches 2004-2005
• List of Tables
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
  • Table 2 Life Expectancy at Birth 2000-2005
  • Table 3 Sales of Otc Healthcare by Sector: Value 2000-2005
  • Table 4 Sales of Otc Healthcare by Sector: % Value Growth 2000-2005
  • Table 5 Otc Healthcare Company Shares by Retail Value 2001-2005
  • Table 6 Otc Healthcare Brand Shares by Retail Value 2002-2005
  • Table 7 Sales of Otc Healthcare by Distribution Format: % Analysis 2000/2005
  • Table 8 Sales of Otc Healthcare by Sector and Distribution Format: % Analysis 2005
  • Table 9 Forecast Sales of Otc Healthcare by Sector: Value 2005-2010
  • Table 10 Forecast Sales of Otc Healthcare by Sector: % Value Growth 2005-2010
  • Table 11 Sales of Analgesics by Subsector: Value 2000-2005
  • Table 12 Sales of Analgesics by Subsector: % Value Growth 2000-2005
  • Table 13 Analgesics Company Shares by Retail Value 2001-2005
  • Table 14 Analgesics Brand Shares by Retail Value 2002-2005
  • Table 15 Forecast Sales of Analgesics by Subsector: Value 2005-2010
  • Table 16 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
  • Table 17 Herbal vs Standard Topical Analgesics 2000/2005